RxDoctor Payments DataLook up a doctor →

James Levine, DO

Rheumatology · Greeley, CONPI 1093793838

Payments from drug & device makers

$129,926in general payments, 2019–2025

Across 349 payments — averaging $372.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$56K
  • Lilly USA, LLC$52K
  • Novartis$6K
  • Gilead$6K
  • Regeneron Healthcare Solutions, Inc.$4K
  • Amgen$3K
  • plus $3K from 8 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$129,926 in reported general payments places this provider in the 85th percentile of 108 rheumatology providers in Colorado.

See all rheumatology providers in Colorado

Medicare billing

Part B allowed, 2024
$3,190,127
Medicare patients
673
Services billed
210,457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Greeley

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →